Table 4.
Mean ADC values in metastatic and reactive cervical lymph nodes
| Mean ADC of reactive LN (×10−6 mm2 s−1) | Level of LN location | Mean ADC of metastatic LN (×10−6 mm2 s−1) | Level of LN location |
|---|---|---|---|
| 1178.0 ± 117.0 | Level III | 948.2 ± 90.4 | Level V |
| 908.5 ± 138.8 | Level III | 1076.6 ± 141.7 | Level V |
| 911.3 ± 54.9 | Level I | 935.3 ± 97.9 | Level III |
| 1074.1 ± 101.6 | Level II | 1126.8 ± 55.8 | Level IV |
| 1336.3 ± 82.7 | Level II | 569.2 ± 127.3 | Level II |
| 1351.6 ± 121.0 | Level III | 572.8 ± 111.7 | Level II |
| 923.5 ± 70.3 | Level II | 486.0 ± 96.0 | Level II |
| 895.0 ± 96.6 | Level II | 412.9 ± 129.8 | Level I |
| 1062.7 ± 126.4 | Level III | 504.6 ± 118.1 | Level III |
| 998.1 ± 113.3 | Level I | 517.0 ± 43.3 | Level II |
| 1091.2 ± 119.1 | Level II | 795.4 ± 120.6 | Level I |
| 1062.2 ± 114.4 | Level III | 624.1 ± 75.0 | Level II |
| 992.2 ± 105.0 | Level II | 640.3 ± 64.8 | Level II |
| 1041.7 ± 66.2 | Level I | 818.9 ± 65.0 | Level I |
| 912.5 ± 156.5 | Level II | 887.3 ± 64.8 | Level III |
| 1082.5 ± 88.0 | Level II | 684.5 ± 97.0 | Level II |
| 1073.7 ± 91.5 | Level III | 610.2 ± 91.7 | Level II |
| 1035.6 ± 40.5 | Level I | 716.9 ± 153.5 | Level II |
| 1014.6 ± 90.9 | Level I | 601.7 ± 134.2 | Level III |
| 1021.9 ± 43.7 | Level II | 645.3 ± 76.7 | Level I |
| 809.3 ± 71.5 | Level II | 572.3 ± 156.5 | Level II |
| 877.3 ± 133.0 | Level II | ||
| 924.4 ± 55.4 | Level II | ||
| 1370.4 ± 46.4 | Level I | ||
| 1003.3 ± 79.0 | Level III | ||
| 940.6 ± 103.1 | Level II | ||
| 959.4 ± 57.7 | Level II | ||
| 947.8 ± 64.1 | Level II | ||
| 1366.5 ± 106.9 | Level III | ||
| 932.3 ± 59.4 | Level I |
ADC, apparent diffusion coefficient; LN, lymph node.